Comparing the effectiveness of small-particle versus large-particle inhaled cortiscosteroid in COPD

Lead Investigator:

 

Research Team:

Status: Complete

Short Description

Small airway changes and dysfunction contribute importantly to airway obstruction in chronic obstructive pulmonary disease (COPD), which is currently treated with inhaled corticosteroids (ICS) and long-acting bronchodilators at Global initiative for Obstructive Lung Disease (GOLD) grades 2–4. This retrospective matched cohort analysis compared effectiveness of a representative small-particle ICS (extrafine beclomethasone) and larger-particle ICS (fluticasone) in primary care patients with COPD.

Documents and Publications

Protocol

Abstracts

Presentations

Final Publications

Additional Material